Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that accounts for the largest proportion of breast cancer-related deaths. Thus, it is imperative to search for novel drug candidates with potent anti-TNBC effects. Recent studies suggest that isoliquiritigenin (ISL) can significantly...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Fu Peng, Liang Xiong, Xiaofang Xie, Hailin Tang, Ruizhen Huang, Cheng Peng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-03-01
coleção:	Frontiers in Pharmacology
Assuntos:	3′,4′,5′,4″-tetramethoxychalcone triple-negative breast cancer apoptosis miR-374a Bax
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fphar.2020.00378/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!